PUBLICATIONS

[25] 

Recent advances in acoustic cavitation-inducible materials for cancer sonotheranostics

JY Park, J Kang, M Kwon, YJ Jeong, H Ju, EJ Heo, C Lee, J Lee, H Byun, H Shin, JR Lee, HS Kim*, W Um*, DG You*. (*denoted as corresponding author)

Nanoscale. 2026.
[LINK] 

[24] 

A ribonucleotide carbohydrate system (iRNC) enhances antigen presentation and controls glioblastoma

HS Kim, J Oh, J Jeon, F Fei, S Parvanian, R Kohler, C Garris, R Weissleder

Theranostics. 2026, (JCR 3.3%, IF 13.3)
[LINK] 

[23]

Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence

Y Kaiser, C Garris, E Marinari, HS Kim, JH Oh, EA Halabi, MH Choi, R Kohler, D Migliorini, R Weissleder

Nature Biomedical Engineering. 2025, (JCR 0.4%, IF 26.4)
[LINK] 

[22]

A myeloid cell-targeted immunostimulant cocktail (MyTai) enhances cancer immunotherapy

HS Kim, G Simpson, J Carrothers, Y Nguyen, R Kohler, S Hong, S Cha, DH Kim, C Garris, R Weissleder

ACS Nano. 2025, (JCR 6.0%, IF 16.0)
[LINK] 

[21]

Fluorinated ribonucleocarbohydrate (RNC) nanoparticles allow ultraefficient mRNA delivery and protein expression in tumor-associated myeloid cells 

HS Kim, G Simpson, F Fei, C Garris, R Weissleder 

J. Am. Chem. Soc. 2025, 147, 14, 11766-11776 (JCR 4.8%, IF 15.6)
[LINK] 

[20]

Targeted SPP1 inhibition of tumor-associated myeloid cells effectively decreases tumor sizes 

B Kartal, C Garris, HS Kim, R Kohler, J Carrothers, EA Halabi. Y Iwanoto, AG Goubet, Y Xie, P Wirapati, MJ Pittet, R Weissleder 

Advanced Science. 2025, 12, 4 (JCR 7.6%, IF 14.3)
[LINK] 

[19]

Oxygenating respiratoid biosystem for therapeutic cell transplantation

SM Jang, CR Yoo, HS Kim, JY Kim, DY Lee

Nature Communications. 2024, 15, 9151 (JCR 5.6%, IF 14.7)
[LINK] 

[18]

Biocompatible and non-degradable microcapsule using ethylamine-bridged EGCG dimer for successful therapeutic cell transplantation

SM Jang, JB Lee, CR Yoo, HS Kim, KM Choi, JS Lee*, DY Lee*

Journal of Controlled Release. 2024. 373, 520-532 (JCR 3.9% IF 10.8)
[LINK] 

[17] 

A non-lipid nucleic acid delivery vector with dendritic cell tropism and stimulation

HS Kim, EA Halabi, N Enbergs, R Kohler, C Garris, R Weissleder 

Theranostics. 2024. 14, 2934-2945 (JCR 3.3%, IF 13.3)
[LINK] 

[16]

A Local Water Molecular-heating Strategy for Near-Infrared Long-lifetime Imaging-guided Photothermal Therapy of Glioblastoma

D Kang*, HS Kim*, S Han, Y Lee, YP Kim, DY Lee, J Lee

Nature Communications. 2023, 14, 2755 (JCR 2.263%, IF 17.694) (*denoted co-first author)
[LINK] 

[15]

Aurozyme: A Revolutionary Catalyst in Colitis, Switching Peroxidase-like to Catalase-like Activity

HS Kim*, S Lee*, DY Lee

Small. 2023, 19, 41, 2302331 (JCR 6.875%, IF 15.153)
[LINK] 

[14]

Inhibition of DAMP Actions in the Tumoral Microenvironment Using Lactoferrin-Glycyrrhizin Conjugate for Glioblastoma Therapy

HS Kim, SC Park, DY Lee

Biomaterials research. 2023, 27, 52 (JCR 3.093%, IF 15.863)
[LINK] 

[13]

Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor

HH Hwang*, HS Kim*, DY Lee 

Journal of Controlled Release. 2023, 335,730-744 (JCR 4.317% IF 11.467) (*denoted co-first author)

[LINK] 

[12]

Nanoarchitectured Conjugates Targeting Angiogenesis: Investigating Heparin-Taurocholate Acid Conjugates (LHT7) as an Advanced Anti-Angiogenic Therapy for Brain Tumor Treatment

HS Kim*, JH Seol*, HH Hwang, DY Lee 

Biomaterials Research.2023, 27, 89 (JCR 3.093%, IF 15.863)
[LINK] 

[11]

Photosensitizing deep-seated cancer cells with photoprotein-conjugated upconversion nanoparticles

SH Park, S Han, S Park, HS Kim, KM Kim, S Kim, DY Lee, J Lee, and YP Kim 

Journal of Nanobiotechnology. 2023, 21, 279 (JCR 8.861% IF 9.429)
[LINK] 

[10]

Milk protein-shelled gold nanoparticles with gastrointestinally active absorption for aurotherapy to brain tumor

HS Kim, SJ Lee, DY Lee 

Bioactive Materials. 2022, 8, 35-48 (JCR 2.062% IF 14.593)
[LINK] 

[9]

DAMP-modulating nanoparticle for successful pancreatic islet and stem cell transplantation 

SB Jang*, SM Jin*, HS Kim*, YY Jeong, SJ Lee, S Hahn, H Lee, HS Lee, JH Kim, and DY Lee

Biomaterials. 2022, 287 (JCR 3.093% IF 12.479) (*denoted co-first author)
[LINK] 

[8]

A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy

HS Kim, M Seo, TE Park, and DY Lee

Journal of Nanobiotechnology. 2022, 20:14 (JCR 5.00% IF 10.435)
[LINK] 

[7]

Nanozyme-based colorimetric biosensor with a systemic quantification algorithm for noninvasive glucose monitoring

HJ Jeon, HS Kim, E Chung, DY Lee

Theranostics. 2022, 12,14, 6308-6338 (JCR 6.475% IF 11.556)
[LINK] 

[6]

Nanomedicine in clinical photodynamic therapy for the treatment of brain tumors

HS Kim, and DY Lee

Biomedicines. 2022, 10(1),96 (JCR 11.786% IF 6.081)

[5]

Engineered aurotherapy for the treatment of multimodal glioblastoma

HS Kim and DY Lee

Brain Tumor Research and Treatment. 2022, 10, 215-220

[4]

Smart Engineering of Gold Nanoparticles to Improve Intestinal Barrier Penetration

HS Kim and DY Lee 

Journal of Industrial and Engineering Chemistry. 2021, 102, 122-134 (JCR 5.278% IF 5.278)

[3]

Multi-layer surface modification of pancreatic islets for magnetic resonance imaging using ferumoxytol

SM Jin, HS Lee, MR. Haque, HN Kim, HJ Kim, BJ Oh, KW Lee, G Kim, HS Kim, DY Lee, JB Park, SJ Kim, Y Byun, JH Kim 

Biomaterials. 2019, 214, 119-224 (JCR 1.299% IF 8.806)

[2]

Near-Infrared-Responsive Cancer Photothermal and Photodynamic Therapy Using Gold Nanoparticles

HS Kim and DY Lee 

Polymers. 2018, 10(9), 961 (JCR 18.824% IF 3.364)

[1]

Photothermal therapy with gold nanoparticles as an anticancer medication

HS Kim and DY Lee 

Journal of Pharmaceutical Investigation. 2017, 47(1), 19-26 (JCR 9.7% IF 5.3)